Wei Shi
48Patents
7h-index
152Co-inventors
72Inventor score
Filing activity: May 13, 2002 → Dec 6, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7842501B2 | Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease | Chemistry; Metallurgy | 22 | Active |
| US7205126B2 | Papilloma pseudovirus and preparation | Chemistry; Metallurgy | 21 | Expired |
| US10301377B2 | Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use | Physics | 11 | Active |
| US8487139B2 | Curcumin and tetrahydrocurcumin derivatives | Human Necessities | 11 | Active |
| US8124408B2 | Preparation of inactivated artificial antigen presenting cells and their use in cell therapies | Human Necessities | 10 | Active |
| US9346791B2 | Itraconazole analogs and use thereof | Human Necessities | 9 | Active |
| US9695230B2 | Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein | Chemistry; Metallurgy | 7 | Active |
| US10035844B2 | Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein | Chemistry; Metallurgy | 6 | Active |
| US10307412B2 | Quinoline derivative against non-small cell lung cancer | Human Necessities | 4 | Active |
| US11597716B2 | N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof | Chemistry; Metallurgy | 3 | Active |
| US8357533B2 | Preparation of inactivated artificial antigen presenting cells and their use in cell therapies | Human Necessities | 3 | Active |
| US6878541B2 | Papilloma pseudo-virus and preparation | Chemistry; Metallurgy | 3 | Expired |
| US11370828B2 | Anti-coronavirus antibodies and methods of use | Physics | 3 | Active |
| US8084256B2 | Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease | Chemistry; Metallurgy | 2 | Active |
| US8232101B2 | Identification of antigenic peptides from multiple myeloma cells | Chemistry; Metallurgy | 2 | Active |
| US8075895B2 | Identification of antigenic peptides from multiple myeloma cells | Chemistry; Metallurgy | 1 | Active |
| US10898566B2 | Zika virus vaccines | Emerging Cross-Sectional Technologies | 1 | Active |
| US9242010B2 | Living copolymer-protein/peptide hybrids for biomedical applications | Human Necessities | 0 | Active |
| US12240811B2 | N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition and uses thereof | Human Necessities | 0 | Active |
| US12371431B2 | Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitor | Human Necessities | 0 | Active |
| US12336996B2 | Drug combination containing TLR7 agonist | Chemistry; Metallurgy | 0 | Active |
| US9119803B2 | Carious tooth vaccine and preparation method | Human Necessities | 0 | Active |
| US9447023B2 | Curcumin and tetrahydrocurcumin derivatives | Human Necessities | 0 | Active |
| US11447541B1 | Anti-coronavirus antibodies and methods of use | Physics | 0 | Active |
| US11692935B2 | Transient-state THz spectrometer for detecting cells and biological macromolecules | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.